slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 87,001-87,030
Pages 3,683
Rows per page 30
Component
87,001-87,030 of 110,471
11
Data presented at EASL 2022 and AASLD 2022.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
12
The slide displays longitudinal data for cohorts E, F, I, J, G, and K, highlighting individual patient responses and key clinical outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
14
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
15
The slide uses a bulleted list with custom circular icons to present clinical safety findings.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
23
Includes both longitudinal efficacy data (line chart) and pharmacokinetic data (bar charts) comparing plasma vs liver concentrations.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
25
The slide maps the viral genome to specific drug targets and highlights partnerships with X-Chem and Proteros.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
05
argenx SE | Investor Presentation Deck | 22 slidesargenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
08
The slide uses a combination of clinical trial charts and a logo-grid of scientific journals to establish credibility.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
10
The slide uses a hub-and-spoke style diagram to categorize commercial growth drivers.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
12
The slide uses a pyramid-like structure to display patient counts for different diseases, with 'clinical' highlighted in the top right.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
14
The slide uses a visual representation of an antibody structure to explain the 'sweeping' mechanism.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
04
The slide uses a combination of line charts for clinical data and a list for safety metrics, followed by a logo-grid of scientific journals.argenx SE | Results Presentation Deck | 11 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
10
The slide uses a hub-and-spoke style layout to connect a central commercial goal to specific strategic pillars.argenx SE | Results Presentation Deck | 11 slides · argenx
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
07
The slide uses a bulleted list to communicate financial health and strategic actions.Arrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · NeedLoop · Why Now1 hit
11
Arrival | Results Presentation Deck | 28 slidesArrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
Arrival | Results Presentation Deck | 28 slidesArrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
17
The slide features a large team photo at the Bicester factory, emphasizing the human element behind the production progress.Arrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
21
Arrival | Results Presentation Deck | 28 slidesArrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
22
Arrival | Results Presentation Deck | 28 slidesArrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
07
The slide outlines the organization's ambition, focus areas, and specific country-level impact examples.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
08
The slide uses a dual-axis chart to show revenue growth alongside emission reduction. It highlights specific targets for 2025 and 2026.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
12
AstraZeneca | ESG Presentation Deck | 16 slidesAstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
14
Includes a map of Africa highlighting current and planned program countries.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
03
Numbered list format used to summarize key company pillars.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
06
The slide uses a timeline framework to show past achievements and future milestones.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · RoadmapLoop · Why Now1 hit
10
The slide uses a vertical process flow to demonstrate the progression of clinical validation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
16
The slide uses a line chart to show MADRS score changes over 12 weeks, highlighting the 25mg dose efficacy.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
21
The slide uses a combination of a disease overview, market sizing metrics, and a 'massive unaddressed need' framework to justify the problem.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses a split-layout with a left-hand sidebar for product specs and a right-hand main area for clinical evidence and trial design.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit